Daesung Microbiological Labs. Co. Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.027x

Daesung Microbiological Labs. Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Daesung Microbiological Labs. Co. Ltd (036480) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩972.26 Million ≈ $658.89K USD) by net assets (₩35.42 Billion ≈ $24.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Daesung Microbiological Labs. Co. Ltd (2012–2025)

Cash flow conversion efficiency of Daesung Microbiological Labs. Co. Ltd from 2012 to 2025. This chart illustrates how Daesung Microbiological Labs. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Daesung Microbiological Labs. Co. Ltd stock price today for real-time trading data and today's change.

Daesung Microbiological Labs. Co. Ltd Cash Flow Conversion Ratio Explained

Daesung Microbiological Labs. Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Daesung Microbiological Labs. Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daesung Microbiological Labs. Co. Ltd ranked by their cash flow conversion efficiency. Also see 036480 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
TRC Construction Public Company Limited BK:TRC	0.069x
Nuriplan Co. Ltd KQ:069140	0.043x
Korea Bio-Gen Co.Ltd KQ:318000	0.032x
Quantum Software SA WAR:QNT	0.102x
Sejoong Co. Ltd KQ:039310	-0.005x
GigaMedia Limited F:GIFN	N/A
Antilles Gold Ltd AU:AAU	-0.033x
Inter-M Corporation KQ:017250	0.042x

Annual Cash Flow Conversion Efficiency for Daesung Microbiological Labs. Co. Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Daesung Microbiological Labs. Co. Ltd from 2012 to 2025. Review 036480 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩35.42 Billion ≈ $24.00 Million	₩1.41 Billion ≈ $955.61K	0.040x	-33.46%
2024-12-31	₩35.15 Billion ≈ $23.82 Million	₩2.10 Billion ≈ $1.43 Million	0.060x	+281.12%
2023-12-31	₩37.35 Billion ≈ $25.31 Million	₩-1.23 Billion ≈ $-836.14K	-0.033x	-211.04%
2022-12-31	₩38.84 Billion ≈ $26.32 Million	₩1.16 Billion ≈ $783.00K	0.030x	-50.04%
2021-12-31	₩37.00 Billion ≈ $25.08 Million	₩2.20 Billion ≈ $1.49 Million	0.060x	-33.19%
2020-12-31	₩36.31 Billion ≈ $24.61 Million	₩3.24 Billion ≈ $2.19 Million	0.089x	+35.07%
2019-12-31	₩35.09 Billion ≈ $23.78 Million	₩2.32 Billion ≈ $1.57 Million	0.066x	-30.56%
2018-12-31	₩33.01 Billion ≈ $22.37 Million	₩3.14 Billion ≈ $2.13 Million	0.095x	+71.29%
2017-12-31	₩30.30 Billion ≈ $20.53 Million	₩1.68 Billion ≈ $1.14 Million	0.055x	-54.29%
2016-12-31	₩29.01 Billion ≈ $19.66 Million	₩3.52 Billion ≈ $2.39 Million	0.121x	-60.26%
2015-12-31	₩25.09 Billion ≈ $17.01 Million	₩7.66 Billion ≈ $5.19 Million	0.305x	+68.35%
2014-12-31	₩21.14 Billion ≈ $14.32 Million	₩3.83 Billion ≈ $2.60 Million	0.181x	+89.22%
2013-12-31	₩19.72 Billion ≈ $13.36 Million	₩1.89 Billion ≈ $1.28 Million	0.096x	-18.93%
2012-12-31	₩19.73 Billion ≈ $13.37 Million	₩2.33 Billion ≈ $1.58 Million	0.118x	--

About Daesung Microbiological Labs. Co. Ltd

KQ:036480 Korea Biotechnology

Market Cap

$13.93 Million

₩20.56 Billion KRW

Market Cap Rank

#26034 Global

#1941 in Korea

Share Price

₩5410.00

Change (1 day)

+0.00%

52-Week Range

₩5410.00 - ₩9880.00

All Time High

₩27216.09